Trial Profile
Effect of Duloxetine 60 mg Once Daily Versus Placebo in Patients With Chronic Low Back Pain. [Efecto de Duloxetina 60 mg, Administrado una Vez al Dia, Frente a Placebo, en Pacientes con Lumbalgia Cronica]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Acronyms HMGC
- Sponsors Eli Lilly and Company
- 14 May 2010 Results published in the Journal of Pain.
- 06 May 2010 Results presented at 29th Annual Scientific Meeting of the American Pain Society.
- 04 Feb 2010 Actual number of patients changed from 395 to 401 according to Eli Lilly media release.